| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
| X25-04-YM1071-1 |
PEG 350 Da |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-2 |
PEG 550 Da |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-3 |
PEG 750 Da |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-4 |
PEG 1 kDa |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-5 |
PEG 2 kDa |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-6 |
PEG 3 kDa |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-7 |
PEG 4 kDa |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-8 |
PEG 5 kDa |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-9 |
PEG 10 kDa |
Alginate |
NGR |
Inquiry
|
| X25-04-YM1071-10 |
PEG 20 kDa |
Alginate |
NGR |
Inquiry
|
Properties
Description
Alginate-PEG-NGR peptide (NGR-PEG-alginate) fuses alginate to NGR via PEG. Tailored PEG (350–20k Da) improves CD13 targeting, prolongs tumor accumulation, and regulates angiogen
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Stability
It is stable under its storage temperature.
Quality Level
Research level
Applications
Alginate-PEG-NGR peptide plays a key role in designing supramolecular assemblies through adamantane-cyclodextrin inclusion.
Storage
Store at -20°C, protect from light and moisture.